Related Experiment Video
Updated: Sep 12, 2025

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
Published on: August 4, 2023
Coagulation Disorders in Pregnancy
1Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic.
Abstract:
Coagulation disorders cause significant morbidity and mortality during pregnancy, and evaluation of hypercoagulability or bleeding are frequently encountered in females of reproductive age. The physiologic changes of the hemostatic system during pregnancy increase the risk of venous thromboembolism and also make laboratory test result interpretation challenging. The risk of thrombosis can be reduced with anticoagulation, but appropriate risk stratification to assure that the benefits outweigh the risks is required. Only patients with severe bleeding disorders typically need preventive management antepartum: however, delivery planning, which has both maternal and fetal implications, is complex and requires coordination between multiple providers.
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...

